Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective. - Wikidata - awgldk - TriplyDB

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective.

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective.

http://www.wikidata.org/entity/Q37409114

about

Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy Reactive oxygen species: sources, consequences and targeted therapy in type 2 diabetes.Antioxidant strategies in the management of diabetic neuropathy.Evaluation of Effect of Nishamalaki on STZ and HFHF Diet Induced Diabetic Neuropathy in Wistar Rats.Molecular cloning and characterization of Schistosoma japonicum aldose reductase.Induced fit docking, pharmacophore modeling, and molecular dynamic simulations on thiazolidinedione derivatives to explore key interactions with Tyr48 in polyol pathway.Epalrestat Stimulated Oxidative Stress, Inflammation, and Fibrogenesis in Mouse Liver.Efficacy and Safety of the Injection of the Traditional Chinese Medicine Puerarin for the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis of 53 Randomized Controlled Trials.Metabolic Syndrome and Neuroprotection.

P2860

Q36329924-E20D89BB-A4CE-4CF5-8B0E-DCB7A44255D7 Q38880678-F7BDD2F1-A7AF-4089-82DE-3B69566FBB50 Q42180667-47C65299-8809-406D-9644-A19472A0D9B6 Q42363959-4E8AF61D-3B96-4F13-A338-BA49C4CA27A1 Q44349734-456166F8-3767-4D3C-BDC0-CF07821BBBC4 Q45747297-302ACA20-013E-4215-9E05-C6C0096D71B5 Q50455650-7C0FBA7E-6AB9-4D35-A554-28DB48D98D52 Q52606109-AE7A110F-ACA7-46AF-95E9-437EA45E2DE0 Q53687232-DFB6EC6C-C960-4FB3-9525-885BFC2D7205

P2860

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective.

http://www.wikidata.org/entity/Q37409114

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective.

@en

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective.

@nl

type

label

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective.

@en

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective.

@nl

prefLabel

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective.

@en

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective.

@nl

P1433

Q37409114-F38C4BCD-1E64-4D66-A915-BCF80D93A749

P1476

Q37409114-B762319E-BB1E-42F8-A0DA-E502545A6E27

P2093

Q37409114-5CD6E3B5-77CA-48D1-9946-8AD5E353BB63

Q37409114-F444F9EC-2410-43A8-857C-F1204A7891C0

P2860

Q37409114-02F4888E-1FFF-4594-ABC8-69A4308C62C3

Q37409114-194566A4-A51A-41CC-AA36-46250ED8955E

Q37409114-1DBF7DB5-4027-4BAB-B4C1-BCA55AE78043

Q37409114-4165B898-71A5-4F77-98BF-D0585F3F8262

Q37409114-BC7C2F0C-3948-4BA5-AB38-2FAD39D02ADE

Q37409114-CF963E16-6A92-4BC8-BC99-35C1CD5CB0CF

Q37409114-D2A8B319-75F8-468E-BF23-A5FA1EA3F255

Q37409114-D5A62476-8D81-43DF-983E-2BC831D6FE60

Q37409114-E6B93987-30CE-4C80-B542-A669C285329C

Q37409114-EB742C78-4F38-4BEA-BD38-D269E0F7A51E

P304

Q37409114-70B6F506-B599-43AD-AE5A-985598DA7331

P31

Q37409114-C30C70DB-AA26-4DE8-A1CC-C410D120AC13

P356

Q37409114-8F1E0BFB-A7DE-413C-971B-1A8E86AC279F

P433

Q37409114-766B7677-13F8-4322-99FD-43F488DACE14

P478

Q37409114-825838A2-838C-438B-B710-D7D388137E93

P577

Q37409114-1FA796E6-E31F-4E26-BD67-F6834C63741C

P698

Q37409114-05015D79-9741-4F61-B9CC-D013468B6895

P921

Q37409114-18531440-93BE-4B55-A431-486770B138DE

P932

Q37409114-62C99332-FD08-4C94-9997-CA1E512157DD

P356

0972-2327.44558

P1433

Annals of Indian Academy of Neurology

P1476

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective.

@en

P2093

Nalini Sharma

http://www.w3.org/2001/XMLSchema#string

S R Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study

Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.

Polyol pathway and diabetic peripheral neuropathy.

Treatments for diabetic neuropathy.

Digital sensory nerve conduction velocity and vibration perception threshold in peripheral neurological test for hand-arm vibration syndrome.

Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitus.

New concepts and insights on pathogenesis and treatment of diabetic complications: polyol pathway and its inhibition.

Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.

Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study.

Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy.

P304

231-235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0972-2327.44558

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19893679

http://www.w3.org/2001/XMLSchema#string

P921

P932

2771994

http://www.w3.org/2001/XMLSchema#string